ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Ginkgetin inhibits non-small cell lung cancer via the HSP90-AKT signaling pathway.

Ruochen Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.